Consultant, Hemato-Oncology

Dr. Shilpa Gupta

Dr. Shilpa Gupta is a seasoned hemato-oncologist with more than fifteen years of expertise in clinical practice, research, and academic medicine, specializing in both benign and malignant blood disorders including leukemia, lymphoma, and myeloma. Her multifaceted experience at renowned institutions such as Holy Spirit Hospital, Bhaktivedanta Hospital, Wockhardt Hospital, and her own Be Positive HemOnc Clinic in Mumbai, has equipped her to diagnose and manage complex hematological conditions and emergencies with precision and compassion.

Dr. Gupta’s clinical interests include multidisciplinary hematology and oncology, excellence in diagnostic and therapeutic decisions, and a strong commitment to evidence-based patient care and education. She is passionate about bridging healthcare gaps in oncology by prioritizing timely intervention, preventive care, and patient-centric service across diverse urban and underserved populations. Actively involved in academic activities, research, and teaching, Dr. Gupta is known for her empathetic approach, collaborative mindset, and high standards of clinical excellence in Mumbai’s medical community.

MBBS: Seth GS Medical College & KEM Hospital, Mumbai (2000–2004)  

MD (Internal Medicine): Grant Medical College & JJ Group of Hospitals, Mumbai (2006–2009)  

Fellowship in Hemato-Oncology: Tata Memorial Hospital, Mumbai (2010–2012)  

Observership in Solid Tumor Oncology: Tata Memorial Hospital, Mumbai (2013)

  • Visiting Consultant, Hemato-Oncology  

Be Positive HemOnc Clinic, Malad East, Mumbai | 2014 – Present  

  • Visiting Consultant, Hemato-Oncology  

Holy Spirit Hospital, Andheri East | 2014 – Present  

  • Visiting Consultant, Hemato-Oncology

Bhaktivedanta Hospital and Research Institute, Mira Road | 2014 – Present  

  • Visiting Consultant, Hemato-Oncology

Wockhardt Hospital, Mira Road | 2014 – Present  

  • Assistant Professor, Department of Medical Oncology  

Sri Aurobindo Institute of Medical Sciences, Indore | 2012 – 2013  

  • Clinical Assistant, Department of Hematology  

Bombay Hospital, Mumbai | July 2009 – Sept 2009  

  • Resident Doctor, Critical Care Unit  

JJ Hospital, Mumbai | Feb 2008 – June 2008  

  • Chief Registrar, Critical Care  

JJ Hospital, Mumbai | Nov 2008

  • 3rd Prize, Poster Presentation, European School of Oncology International Conference on Malignant Lymphoma (2012)  
  • Distinction in Microbiology and Biochemistry during MBBS  
  • Recipient of JRD Tata scholarship (entire MBBS tenure)  
  • Top 150 rank in PGM-CET Medical Entrance (2006)  
  • Top 50 rank in MH-CET MBBS Entrance (2000)
  • Shilpa Gupta et al., “Parenthood in patients with acute promyelocytic leukemia after treatment with arsenic trioxide: a case series.” Leukemia & Lymphoma, Informa Healthcare, UK, 2012
  • Book Chapter: “Gastrointestinal lymphomas,” Recent Advances in Surgery-2012, Jaypee Publications
  • FAQs in Bone Marrow Transplantation (Malad Medical Association, 2017)
  • Poster Presentation: Dasatinib as second-line therapy in Chronic Myeloid Leukemia, Hematocon 2011 (ISHTM, Chandigarh)
  • M.D. Dissertation supervised by Prof. V.K. Joglekar, DM, DNB Cardio:
  • Principal Investigator and Co-investigator in Phase III clinical trials for cancer, lymphoma, ovarian, and pancreatic malignancies (2015–2023)

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct head and neck cancer case study using TCR-p53 therapy in inoperable squamous cell carcinoma
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male